KLRK1 and colorectal cancer: An mRNA based transient NKG2D CAR-NK cells without DAP10 but CD27/28, enhance NK cell tumor responses significantly against various solid tumor cell lines in vitro and demonstrating therapeutic benefits in mice with established colorectal cancer (68).